Gene · 1806
Papers4,420
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
621 to 640 of 4,420
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| The development of BVDU: An odyssey. | Antivir Chem Chemother | 2023 | 36710501 | PubTator, text mining | PubMed |
| Alterations of plasma exosomal proteins and motabolies are associated with the progression of castration-resistant prostate cancer. | J Transl Med | 2023 | 36681849 | PubTator, text mining | PubMed |
| Mammalian dihydropyrimidine dehydrogenase: Added mechanistic details from transient-state analysis of charge transfer complexes. | Arch Biochem Biophys | 2023 | 36681231 | PubTator, text mining | PubMed |
| Folic-Acid-Conjugated Thermoresponsive Polymeric Particles for Targeted Delivery of 5-Fluorouracil to CRC Cells. | Int J Mol Sci | 2023 | 36674883 | PubTator, text mining | PubMed |
| Identification of Novel Pathways Regulated by APE1/Ref-1 in Human Retinal Endothelial Cells. | Int J Mol Sci | 2023 | 36674619 | PubTator, text mining | PubMed |
| The Power of Clinical Diagnosis for Deciphering Complex Genetic Mechanisms in Rare Diseases. | Genes (Basel) | 2023 | 36672937 | PubTator, text mining | PubMed |
| Exploring the Use of Cold Atmospheric Plasma to Overcome Drug Resistance in Cancer. | Biomedicines | 2023 | 36672716 | PubTator, text mining | PubMed |
| A Transcriptomic Regulatory Network among miRNAs, lncRNAs, circRNAs, and mRNAs Associated with L-leucine-induced Proliferation of Equine Satellite Cells. | Animals (Basel) | 2023 | 36670748 | PubTator, text mining | PubMed |
| Inhibition of HSD17B13 protects against liver fibrosis by inhibition of pyrimidine catabolism in nonalcoholic steatohepatitis. | Proc Natl Acad Sci U S A | 2023 | 36669104 | PubTator, text mining | PubMed |
| Real-Life Effectivity of Dose Intensity Reduction of First-Line mFOLFIRI-Based Treatment of Metastatic Colorectal Cancers: Sometimes Less Is More. | Curr Oncol | 2023 | 36661718 | PubTator, text mining | PubMed |
| DPYD Exon 4 Deletion Associated with Fluoropyrimidine Toxicity and Importance of Copy Number Variation. | Curr Oncol | 2023 | 36661700 | PubTator, text mining | PubMed |
| Genome-scale metabolic reconstruction of 7,302 human microorganisms for personalized medicine. | Nat Biotechnol | 2023 | 36658342 | PubTator, text mining | PubMed |
| An efficient genotyper and star-allele caller for pharmacogenomics. | Genome Res | 2023 | 36657977 | PubTator, text mining | PubMed |
Impact of prior chemotherapy with two different fluoropyrimidines on the efficacy of capecitabine plus irinotecan or FOLFIRI with or without bevacizumab in metastatic colorectal cancer: a post hoc analysis of the AXEPT study. | Cancer Commun (Lond) | 2023 | 36647206 | PubTator, text mining | PubMed |
| Novel strategies to reverse chemoresistance in colorectal cancer. | Cancer Med | 2023 | 36645225 | PubTator, text mining | PubMed |
| Renal impairment and abnormal liver function tests in pre-therapeutic phenotype-based DPD deficiency screening using uracilemia: a comprehensive population-based study in 1138 patients. | Ther Adv Med Oncol | 2023 | 36643657 | PubTator, text mining | PubMed |
| DPYD genotyping and predicting fluoropyrimidine toxicity: where do we stand? | Pharmacogenomics | 2023 | 36636997 | PubTator, text mining | PubMed |
| c-Myc-IMPDH1/2 axis promotes tumourigenesis by regulating GTP metabolic reprogramming. | Clin Transl Med | 2023 | 36629054 | PubTator, text mining | PubMed |
| Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency. | Eur J Cancer | 2023 | 36621118 | PubTator, text mining | PubMed |
| Potential Impact of Pharmacogenomic Single Nucleotide Variants in a Rural Caucasian Population. | J Appl Lab Med | 2023 | 36611001 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/1806/papers?page=32